Literature DB >> 23506877

SLC18: Vesicular neurotransmitter transporters for monoamines and acetylcholine.

Hakeem O Lawal1, David E Krantz.   

Abstract

The exocytotic release of neurotransmitters requires active transport into synaptic vesicles and other types of secretory vesicles. Members of the SLC18 family perform this function for acetylcholine (SLC18A3, the vesicular acetylcholine transporter or VAChT) and monoamines such as dopamine and serotonin (SLC18A1 and 2, the vesicular monoamine transporters VMAT1 and 2, respectively). To date, no specific diseases have been attributed to a mutation in an SLC18 family member; however, polymorphisms in SLC18A1 and SLC18A2 may confer risk for some neuropsychiatric disorders. Additional members of this family include SLC18A4, expressed in insects, and SLC18B1, the function of which is not known. SLC18 is part of the Drug:H(+) Antiporter-1 Family (DHA1, TCID 2.A.1.2) within the Major Facilitator Superfamily (MFS, TCID 2.A.1).
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23506877      PMCID: PMC3727660          DOI: 10.1016/j.mam.2012.07.005

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  35 in total

Review 1.  Pharmacology of neurotransmitter transport into secretory vesicles.

Authors:  Farrukh A Chaudhry; Jean-Luc Boulland; Monica Jenstad; May K L Bredahl; Robert H Edwards
Journal:  Handb Exp Pharmacol       Date:  2008

2.  Endocytosis in neurons: editorial introduction and overview.

Authors:  Reinhard Jahn; Silvio O Rizzoli
Journal:  Traffic       Date:  2007-07-20       Impact factor: 6.215

3.  The vesicular acetylcholine transporter is required for neuromuscular development and function.

Authors:  Braulio M de Castro; Xavier De Jaeger; Cristina Martins-Silva; Ricardo D F Lima; Ernani Amaral; Cristiane Menezes; Patricia Lima; Cintia M L Neves; Rita G Pires; Thomas W Gould; Ian Welch; Christopher Kushmerick; Cristina Guatimosim; Ivan Izquierdo; Martin Cammarota; R Jane Rylett; Marcus V Gomez; Marc G Caron; Ronald W Oppenheim; Marco A M Prado; Vania F Prado
Journal:  Mol Cell Biol       Date:  2009-07-27       Impact factor: 4.272

4.  Possible important pair of acidic residues in vesicular acetylcholine transporter.

Authors:  Parul Khare; Ana M Ojeda; Ananda Chandrasekaran; Stanley M Parsons
Journal:  Biochemistry       Date:  2010-04-13       Impact factor: 3.162

5.  Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons.

Authors:  Eugene V Mosharov; Kristin E Larsen; Ellen Kanter; Kester A Phillips; Krystal Wilson; Yvonne Schmitz; David E Krantz; Kazuto Kobayashi; Robert H Edwards; David Sulzer
Journal:  Neuron       Date:  2009-04-30       Impact factor: 17.173

Review 6.  Trafficking of vesicular neurotransmitter transporters.

Authors:  Hao Fei; Anna Grygoruk; Elizabeth S Brooks; Audrey Chen; David E Krantz
Journal:  Traffic       Date:  2008-05-26       Impact factor: 6.215

7.  Drosophila vesicular monoamine transporter mutants can adapt to reduced or eliminated vesicular stores of dopamine and serotonin.

Authors:  Anne F Simon; Richard Daniels; Rafael Romero-Calderón; Anna Grygoruk; Hui-Yun Chang; Rod Najibi; David Shamouelian; Evelyn Salazar; Mordecai Solomon; Larry C Ackerson; Nigel T Maidment; Aaron Diantonio; David E Krantz
Journal:  Genetics       Date:  2008-11-24       Impact factor: 4.562

8.  Identification of two risk haplotypes for schizophrenia and bipolar disorder in the synaptic vesicle monoamine transporter gene (SVMT).

Authors:  Blanca Gutiérrez; Araceli Rosa; Sergi Papiol; Francisco J Arrufat; Rosa Catalán; Purificación Salgado; Víctor Peralta; Manuel J Cuesta; Lourdes Fañanás
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-06-05       Impact factor: 3.568

Review 9.  Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons.

Authors:  Thomas S Guillot; Gary W Miller
Journal:  Mol Neurobiol       Date:  2009-03-04       Impact factor: 5.590

10.  A glial variant of the vesicular monoamine transporter is required to store histamine in the Drosophila visual system.

Authors:  Rafael Romero-Calderón; Guido Uhlenbrock; Jolanta Borycz; Anne F Simon; Anna Grygoruk; Susan K Yee; Amy Shyer; Larry C Ackerson; Nigel T Maidment; Ian A Meinertzhagen; Bernhard T Hovemann; David E Krantz
Journal:  PLoS Genet       Date:  2008-11-07       Impact factor: 5.917

View more
  31 in total

Review 1.  Understanding transport by the major facilitator superfamily (MFS): structures pave the way.

Authors:  Esben M Quistgaard; Christian Löw; Fatma Guettou; Pär Nordlund
Journal:  Nat Rev Mol Cell Biol       Date:  2016-01-13       Impact factor: 94.444

2.  Immunolocalization of the vesicular acetylcholine transporter in larval and adult Drosophila neurons.

Authors:  Sridhar Boppana; Natalie Kendall; Opeyemi Akinrinsola; Daniel White; Krushali Patel; Hakeem Lawal
Journal:  Neurosci Lett       Date:  2017-02-07       Impact factor: 3.046

3.  The Concise Guide to PHARMACOLOGY 2013/14: transporters.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 4.  Competition as a way of life for H(+)-coupled antiporters.

Authors:  Shimon Schuldiner
Journal:  J Mol Biol       Date:  2014-05-24       Impact factor: 5.469

Review 5.  Physiology of Astroglia.

Authors:  Alexei Verkhratsky; Maiken Nedergaard
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

6.  Modulation of social space by dopamine in Drosophila melanogaster, but no effect on the avoidance of the Drosophila stress odorant.

Authors:  Robert W Fernandez; Adesanya A Akinleye; Marat Nurilov; Omar Feliciano; Matthew Lollar; Rami R Aijuri; Janis M O'Donnell; Anne F Simon
Journal:  Biol Lett       Date:  2017-08       Impact factor: 3.703

Review 7.  Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.

Authors:  Kelly M Lohr; Shababa T Masoud; Ali Salahpour; Gary W Miller
Journal:  Eur J Neurosci       Date:  2016-09-02       Impact factor: 3.386

8.  Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group.

Authors:  William Temple; Lori Mendelsohn; Grace E Kim; Erin Nekritz; W Clay Gustafson; Lawrence Lin; Kathy Giacomini; Arlene Naranjo; Collin Van Ryn; Gregory A Yanik; Susan G Kreissman; Michael Hogarty; Katherine K Matthay; Steven G DuBois
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09-04       Impact factor: 9.236

Review 9.  Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors.

Authors:  Nicki Niemann; Joseph Jankovic
Journal:  Drugs       Date:  2018-04       Impact factor: 9.546

10.  The redistribution of Drosophila vesicular monoamine transporter mutants from synaptic vesicles to large dense-core vesicles impairs amine-dependent behaviors.

Authors:  Anna Grygoruk; Audrey Chen; Ciara A Martin; Hakeem O Lawal; Hao Fei; Gabriel Gutierrez; Traci Biedermann; Rod Najibi; Richard Hadi; Amit K Chouhan; Niall P Murphy; Felix E Schweizer; Gregory T Macleod; Nigel T Maidment; David E Krantz
Journal:  J Neurosci       Date:  2014-05-14       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.